New drug G1090N tested in healthy volunteers for first time
NCT ID NCT07110441
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase trial tested the safety and how the body handles a new drug called G1090N in 52 healthy adults. Participants received single or multiple doses up to 1200 mg. The goal was to measure drug levels in blood and urine, and check for side effects. This is a first step before testing the drug in people with acute-on-chronic liver failure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
G1090N
What this could lead to
If successful, this could support further testing of G1090N as a potential treatment for acute-on-chronic liver failure.
What could go wrong
This is a very early Phase 1 study in healthy volunteers, not patients. It only measures safety and drug processing, not whether the drug works for liver failure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE-ON-CHRONIC LIVER FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Anaheim Clinical Trials, LLC
Anaheim, California, 92801, United States